Humana (HUM), a leading health insurer, continues to struggle amidst mixed financials and rising medical costs. Acknowledged by PEOPLE Magazine as one of the top 100 Companies that Care, the company also faces a
$90M Medicare Part D Fraud Whistleblower Lawsuit settlement. Despite these challenges, dividends are paid out regularly, indicating a stable income for investors. Notably, the Medicare Advantage part of the health insurer showcases significant strength, surpassing Q2 earnings estimates. New partnerships are being established, exhibiting Humana's ongoing growth and the expansion of its CenterWell facilities. However,
shares plummeted due to an unexpected rise in Medicare Advantage rates, causing concern among shareholders. Moreover, Humana pulled its 2025 profit forecast due to disappointing Medicare rates. Despite all the setbacks, there is optimism among some industry experts that Humana is set up for Long-Term Success. However, the mixed financials and ongoing lawsuits reaffirm the need to exercise caution while investing.
Humana HUM News Analytics from Tue, 02 Jan 2024 08:00:00 GMT to Thu, 22 Aug 2024 14:35:37 GMT -
Rating -4
- Innovation 3
- Information 8
- Rumor -6
